The recent instability in global supply have highlighted the necessity of securing essential medications like Ivermectin. Trusting on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, price fluctuations, and even trade risks. Transitioning towards domestic production of Ivermectin offers a multi